Renal transplantation.
Renal Transplantation has progressed from an experiment in surgery, nephrology, and immunology to the preferred means of renal replacement therapy for patients with end-stage renal disease. Patient and graft survival rates are spectacular in the short run and improving steadily in the long. The current state of the art reflects deepened understanding of the alloimmune response and the T lymphocyte activation cascade in part driving the discovery of ever more potent immunosuppressive agents. Important issues remain such as chronic allograft dysfunction, the organ shortage, and tolerance induction. In this review, we will look at the history, the expanding treatment options based on better understanding of the immunobiology of alloantigen response, and the persistent challenges awaiting.
Department of Medicine, Division of Nephrology, Vanderbilt Medical Center, Nashville, TN 37232-2372, USA.
V
V
Ramanathan
S
S
Goral
J H
JH
Helderman
D005544:Forecasting; D006085:Graft Survival; D049673:History, 20th Century; D006801:Humans; D007108:Immune Tolerance; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000266:history / Q000601:surgery*; D016030:Kidney Transplantation / Q000266:history / Q000276:immunology / Q000639:trends
D007166:Immunosuppressive Agents